Skip to Content
Merck
CN

IRAK-4 inhibitors. Part 1: a series of amides.

Bioorganic & medicinal chemistry letters (2008-05-14)
George M Buckley, Lewis Gowers, Alicia Perez Higueruelo, Kerry Jenkins, Stephen R Mack, Trevor Morgan, David M Parry, William R Pitt, Oliver Rausch, Marianna D Richard, Verity Sabin, Joanne L Fraser
ABSTRACT

The synthesis and profile of a series of amides are described. Some of these compounds were potent IRAK-4 inhibitors and two examples were evaluated in vivo.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
JH-I-25, ≥98% (HPLC)